Medical Devices & Consumables
Global Passive Digital Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 606222
- Pages: 167
- Figures: 164
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Passive Digital Biomarker market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Pfizer
Philips
Novartis
Johnson & Johnson
GlaxoSmithKline
GE Healthcare
Asahi Kasei
Abbott Laboratories
Merck
Bayer
Sanofi
Koneksa Health
Huma Therapeutics
Roche
Biogen
Segment by Type
Physiological Parameters Type
Behavioral Activity Type
Environmental Factors Type
Others
Segment by Application
Health Management
Disease Prevention
Clinical Diagnosis
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Passive Digital Biomarker study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Passive Digital Biomarker market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Pfizer
Philips
Novartis
Johnson & Johnson
GlaxoSmithKline
GE Healthcare
Asahi Kasei
Abbott Laboratories
Merck
Bayer
Sanofi
Koneksa Health
Huma Therapeutics
Roche
Biogen
Segment by Type
Physiological Parameters Type
Behavioral Activity Type
Environmental Factors Type
Others
Segment by Application
Health Management
Disease Prevention
Clinical Diagnosis
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Passive Digital Biomarker study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Passive Digital Biomarker: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Passive Digital Biomarker Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Physiological Parameters Type
1.2.3 Behavioral Activity Type
1.2.4 Environmental Factors Type
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Passive Digital Biomarker Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Management
1.3.3 Disease Prevention
1.3.4 Clinical Diagnosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Passive Digital Biomarker Revenue Estimates and Forecasts 2020-2031
2.2 Global Passive Digital Biomarker Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Passive Digital Biomarker Sales Estimates and Forecasts 2020-2031
2.4 Global Passive Digital Biomarker Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Passive Digital Biomarker Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Passive Digital Biomarker Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Physiological Parameters Type Market Size by Manufacturers
3.5.2 Behavioral Activity Type Market Size by Manufacturers
3.5.3 Environmental Factors Type Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Passive Digital Biomarker Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Passive Digital Biomarker Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Passive Digital Biomarker Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Passive Digital Biomarker Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Passive Digital Biomarker Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
6.4 North America Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Passive Digital Biomarker Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
7.4 Europe Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Passive Digital Biomarker Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Passive Digital Biomarker Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
9.4 Central and South America Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Passive Digital Biomarker Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Passive Digital Biomarker Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Passive Digital Biomarker Product Models, Descriptions and Specifications
11.1.4 Pfizer Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer Passive Digital Biomarker Sales by Product in 2024
11.1.6 Pfizer Passive Digital Biomarker Sales by Application in 2024
11.1.7 Pfizer Passive Digital Biomarker Sales by Geographic Area in 2024
11.1.8 Pfizer Passive Digital Biomarker SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 Philips
11.2.1 Philips Corporation Information
11.2.2 Philips Business Overview
11.2.3 Philips Passive Digital Biomarker Product Models, Descriptions and Specifications
11.2.4 Philips Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Philips Passive Digital Biomarker Sales by Product in 2024
11.2.6 Philips Passive Digital Biomarker Sales by Application in 2024
11.2.7 Philips Passive Digital Biomarker Sales by Geographic Area in 2024
11.2.8 Philips Passive Digital Biomarker SWOT Analysis
11.2.9 Philips Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Business Overview
11.3.3 Novartis Passive Digital Biomarker Product Models, Descriptions and Specifications
11.3.4 Novartis Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novartis Passive Digital Biomarker Sales by Product in 2024
11.3.6 Novartis Passive Digital Biomarker Sales by Application in 2024
11.3.7 Novartis Passive Digital Biomarker Sales by Geographic Area in 2024
11.3.8 Novartis Passive Digital Biomarker SWOT Analysis
11.3.9 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Passive Digital Biomarker Product Models, Descriptions and Specifications
11.4.4 Johnson & Johnson Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Johnson & Johnson Passive Digital Biomarker Sales by Product in 2024
11.4.6 Johnson & Johnson Passive Digital Biomarker Sales by Application in 2024
11.4.7 Johnson & Johnson Passive Digital Biomarker Sales by Geographic Area in 2024
11.4.8 Johnson & Johnson Passive Digital Biomarker SWOT Analysis
11.4.9 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Passive Digital Biomarker Product Models, Descriptions and Specifications
11.5.4 GlaxoSmithKline Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 GlaxoSmithKline Passive Digital Biomarker Sales by Product in 2024
11.5.6 GlaxoSmithKline Passive Digital Biomarker Sales by Application in 2024
11.5.7 GlaxoSmithKline Passive Digital Biomarker Sales by Geographic Area in 2024
11.5.8 GlaxoSmithKline Passive Digital Biomarker SWOT Analysis
11.5.9 GlaxoSmithKline Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Corporation Information
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Passive Digital Biomarker Product Models, Descriptions and Specifications
11.6.4 GE Healthcare Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 GE Healthcare Recent Developments
11.7 Asahi Kasei
11.7.1 Asahi Kasei Corporation Information
11.7.2 Asahi Kasei Business Overview
11.7.3 Asahi Kasei Passive Digital Biomarker Product Models, Descriptions and Specifications
11.7.4 Asahi Kasei Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Asahi Kasei Recent Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Corporation Information
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Passive Digital Biomarker Product Models, Descriptions and Specifications
11.8.4 Abbott Laboratories Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Laboratories Recent Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Business Overview
11.9.3 Merck Passive Digital Biomarker Product Models, Descriptions and Specifications
11.9.4 Merck Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Merck Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Business Overview
11.10.3 Bayer Passive Digital Biomarker Product Models, Descriptions and Specifications
11.10.4 Bayer Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Bayer Recent Developments
11.11 Sanofi
11.11.1 Sanofi Corporation Information
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Passive Digital Biomarker Product Models, Descriptions and Specifications
11.11.4 Sanofi Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Sanofi Recent Developments
11.12 Koneksa Health
11.12.1 Koneksa Health Corporation Information
11.12.2 Koneksa Health Business Overview
11.12.3 Koneksa Health Passive Digital Biomarker Product Models, Descriptions and Specifications
11.12.4 Koneksa Health Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Koneksa Health Recent Developments
11.13 Huma Therapeutics
11.13.1 Huma Therapeutics Corporation Information
11.13.2 Huma Therapeutics Business Overview
11.13.3 Huma Therapeutics Passive Digital Biomarker Product Models, Descriptions and Specifications
11.13.4 Huma Therapeutics Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Huma Therapeutics Recent Developments
11.14 Roche
11.14.1 Roche Corporation Information
11.14.2 Roche Business Overview
11.14.3 Roche Passive Digital Biomarker Product Models, Descriptions and Specifications
11.14.4 Roche Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Roche Recent Developments
11.15 Biogen
11.15.1 Biogen Corporation Information
11.15.2 Biogen Business Overview
11.15.3 Biogen Passive Digital Biomarker Product Models, Descriptions and Specifications
11.15.4 Biogen Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Biogen Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Passive Digital Biomarker Industry Chain
12.2 Passive Digital Biomarker Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Passive Digital Biomarker Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Passive Digital Biomarker Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Passive Digital Biomarker Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Passive Digital Biomarker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Passive Digital Biomarker: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Passive Digital Biomarker Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Physiological Parameters Type
1.2.3 Behavioral Activity Type
1.2.4 Environmental Factors Type
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Passive Digital Biomarker Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Management
1.3.3 Disease Prevention
1.3.4 Clinical Diagnosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Passive Digital Biomarker Revenue Estimates and Forecasts 2020-2031
2.2 Global Passive Digital Biomarker Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Passive Digital Biomarker Sales Estimates and Forecasts 2020-2031
2.4 Global Passive Digital Biomarker Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Passive Digital Biomarker Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Passive Digital Biomarker Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Physiological Parameters Type Market Size by Manufacturers
3.5.2 Behavioral Activity Type Market Size by Manufacturers
3.5.3 Environmental Factors Type Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Passive Digital Biomarker Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Passive Digital Biomarker Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Passive Digital Biomarker Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Passive Digital Biomarker Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Passive Digital Biomarker Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
6.4 North America Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Passive Digital Biomarker Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
7.4 Europe Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Passive Digital Biomarker Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Passive Digital Biomarker Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
9.4 Central and South America Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Passive Digital Biomarker Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Passive Digital Biomarker Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Passive Digital Biomarker Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Passive Digital Biomarker Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Passive Digital Biomarker Product Models, Descriptions and Specifications
11.1.4 Pfizer Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer Passive Digital Biomarker Sales by Product in 2024
11.1.6 Pfizer Passive Digital Biomarker Sales by Application in 2024
11.1.7 Pfizer Passive Digital Biomarker Sales by Geographic Area in 2024
11.1.8 Pfizer Passive Digital Biomarker SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 Philips
11.2.1 Philips Corporation Information
11.2.2 Philips Business Overview
11.2.3 Philips Passive Digital Biomarker Product Models, Descriptions and Specifications
11.2.4 Philips Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Philips Passive Digital Biomarker Sales by Product in 2024
11.2.6 Philips Passive Digital Biomarker Sales by Application in 2024
11.2.7 Philips Passive Digital Biomarker Sales by Geographic Area in 2024
11.2.8 Philips Passive Digital Biomarker SWOT Analysis
11.2.9 Philips Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Business Overview
11.3.3 Novartis Passive Digital Biomarker Product Models, Descriptions and Specifications
11.3.4 Novartis Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novartis Passive Digital Biomarker Sales by Product in 2024
11.3.6 Novartis Passive Digital Biomarker Sales by Application in 2024
11.3.7 Novartis Passive Digital Biomarker Sales by Geographic Area in 2024
11.3.8 Novartis Passive Digital Biomarker SWOT Analysis
11.3.9 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Passive Digital Biomarker Product Models, Descriptions and Specifications
11.4.4 Johnson & Johnson Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Johnson & Johnson Passive Digital Biomarker Sales by Product in 2024
11.4.6 Johnson & Johnson Passive Digital Biomarker Sales by Application in 2024
11.4.7 Johnson & Johnson Passive Digital Biomarker Sales by Geographic Area in 2024
11.4.8 Johnson & Johnson Passive Digital Biomarker SWOT Analysis
11.4.9 Johnson & Johnson Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Passive Digital Biomarker Product Models, Descriptions and Specifications
11.5.4 GlaxoSmithKline Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 GlaxoSmithKline Passive Digital Biomarker Sales by Product in 2024
11.5.6 GlaxoSmithKline Passive Digital Biomarker Sales by Application in 2024
11.5.7 GlaxoSmithKline Passive Digital Biomarker Sales by Geographic Area in 2024
11.5.8 GlaxoSmithKline Passive Digital Biomarker SWOT Analysis
11.5.9 GlaxoSmithKline Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Corporation Information
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Passive Digital Biomarker Product Models, Descriptions and Specifications
11.6.4 GE Healthcare Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 GE Healthcare Recent Developments
11.7 Asahi Kasei
11.7.1 Asahi Kasei Corporation Information
11.7.2 Asahi Kasei Business Overview
11.7.3 Asahi Kasei Passive Digital Biomarker Product Models, Descriptions and Specifications
11.7.4 Asahi Kasei Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Asahi Kasei Recent Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Corporation Information
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Passive Digital Biomarker Product Models, Descriptions and Specifications
11.8.4 Abbott Laboratories Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Laboratories Recent Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Business Overview
11.9.3 Merck Passive Digital Biomarker Product Models, Descriptions and Specifications
11.9.4 Merck Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Merck Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Business Overview
11.10.3 Bayer Passive Digital Biomarker Product Models, Descriptions and Specifications
11.10.4 Bayer Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Bayer Recent Developments
11.11 Sanofi
11.11.1 Sanofi Corporation Information
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Passive Digital Biomarker Product Models, Descriptions and Specifications
11.11.4 Sanofi Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Sanofi Recent Developments
11.12 Koneksa Health
11.12.1 Koneksa Health Corporation Information
11.12.2 Koneksa Health Business Overview
11.12.3 Koneksa Health Passive Digital Biomarker Product Models, Descriptions and Specifications
11.12.4 Koneksa Health Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Koneksa Health Recent Developments
11.13 Huma Therapeutics
11.13.1 Huma Therapeutics Corporation Information
11.13.2 Huma Therapeutics Business Overview
11.13.3 Huma Therapeutics Passive Digital Biomarker Product Models, Descriptions and Specifications
11.13.4 Huma Therapeutics Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Huma Therapeutics Recent Developments
11.14 Roche
11.14.1 Roche Corporation Information
11.14.2 Roche Business Overview
11.14.3 Roche Passive Digital Biomarker Product Models, Descriptions and Specifications
11.14.4 Roche Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Roche Recent Developments
11.15 Biogen
11.15.1 Biogen Corporation Information
11.15.2 Biogen Business Overview
11.15.3 Biogen Passive Digital Biomarker Product Models, Descriptions and Specifications
11.15.4 Biogen Passive Digital Biomarker Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Biogen Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Passive Digital Biomarker Industry Chain
12.2 Passive Digital Biomarker Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Passive Digital Biomarker Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Passive Digital Biomarker Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Passive Digital Biomarker Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Passive Digital Biomarker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Passive Digital Biomarker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Passive Digital Biomarker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Passive Digital Biomarker Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Passive Digital Biomarker Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Passive Digital Biomarker Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Passive Digital Biomarker Sales by Region (2020-2025) & (K Units)
Table 8. Global Passive Digital Biomarker Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Passive Digital Biomarker Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Passive Digital Biomarker Sales Share by Manufacturers (2020-2025)
Table 12. Global Passive Digital Biomarker Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Passive Digital Biomarker Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Passive Digital Biomarker by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Digital Biomarker as of 2024)
Table 16. Global Passive Digital Biomarker Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Passive Digital Biomarker Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Passive Digital Biomarker Manufacturing Base and Headquarters
Table 19. Global Passive Digital Biomarker Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Passive Digital Biomarker Sales by Type (2020-2025) & (K Units)
Table 23. Global Passive Digital Biomarker Sales by Type (2026-2031) & (K Units)
Table 24. Global Passive Digital Biomarker Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Passive Digital Biomarker Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Passive Digital Biomarker ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Passive Digital Biomarker Sales by Application (2020-2025) & (K Units)
Table 29. Global Passive Digital Biomarker Sales by Application (2026-2031) & (K Units)
Table 30. Passive Digital Biomarker High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Passive Digital Biomarker Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Passive Digital Biomarker Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Passive Digital Biomarker ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 37. North America Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 40. Europe Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 45. Southeast Asia Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Passive Digital Biomarker Investment Opportunities and Key Challenges
Table 47. Central and South America Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Passive Digital Biomarker Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer Passive Digital Biomarker SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. Philips Corporation Information
Table 60. Philips Description and Major Businesses
Table 61. Philips Product Models, Descriptions and Specifications
Table 62. Philips Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Philips Sales Value Proportion by Product in 2024
Table 64. Philips Sales Value Proportion by Application in 2024
Table 65. Philips Sales Value Proportion by Geographic Area in 2024
Table 66. Philips Passive Digital Biomarker SWOT Analysis
Table 67. Philips Recent Developments
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Major Businesses
Table 70. Novartis Product Models, Descriptions and Specifications
Table 71. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novartis Sales Value Proportion by Product in 2024
Table 73. Novartis Sales Value Proportion by Application in 2024
Table 74. Novartis Sales Value Proportion by Geographic Area in 2024
Table 75. Novartis Passive Digital Biomarker SWOT Analysis
Table 76. Novartis Recent Developments
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Major Businesses
Table 79. Johnson & Johnson Product Models, Descriptions and Specifications
Table 80. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 82. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 83. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 84. Johnson & Johnson Passive Digital Biomarker SWOT Analysis
Table 85. Johnson & Johnson Recent Developments
Table 86. GlaxoSmithKline Corporation Information
Table 87. GlaxoSmithKline Description and Major Businesses
Table 88. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 89. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GlaxoSmithKline Sales Value Proportion by Product in 2024
Table 91. GlaxoSmithKline Sales Value Proportion by Application in 2024
Table 92. GlaxoSmithKline Sales Value Proportion by Geographic Area in 2024
Table 93. GlaxoSmithKline Passive Digital Biomarker SWOT Analysis
Table 94. GlaxoSmithKline Recent Developments
Table 95. GE Healthcare Corporation Information
Table 96. GE Healthcare Description and Major Businesses
Table 97. GE Healthcare Product Models, Descriptions and Specifications
Table 98. GE Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. GE Healthcare Recent Developments
Table 100. Asahi Kasei Corporation Information
Table 101. Asahi Kasei Description and Major Businesses
Table 102. Asahi Kasei Product Models, Descriptions and Specifications
Table 103. Asahi Kasei Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Asahi Kasei Recent Developments
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Major Businesses
Table 107. Abbott Laboratories Product Models, Descriptions and Specifications
Table 108. Abbott Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Abbott Laboratories Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Product Models, Descriptions and Specifications
Table 113. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Merck Recent Developments
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Product Models, Descriptions and Specifications
Table 118. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Bayer Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Product Models, Descriptions and Specifications
Table 123. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Sanofi Recent Developments
Table 125. Koneksa Health Corporation Information
Table 126. Koneksa Health Description and Major Businesses
Table 127. Koneksa Health Product Models, Descriptions and Specifications
Table 128. Koneksa Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Koneksa Health Recent Developments
Table 130. Huma Therapeutics Corporation Information
Table 131. Huma Therapeutics Description and Major Businesses
Table 132. Huma Therapeutics Product Models, Descriptions and Specifications
Table 133. Huma Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Huma Therapeutics Recent Developments
Table 135. Roche Corporation Information
Table 136. Roche Description and Major Businesses
Table 137. Roche Product Models, Descriptions and Specifications
Table 138. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Roche Recent Developments
Table 140. Biogen Corporation Information
Table 141. Biogen Description and Major Businesses
Table 142. Biogen Product Models, Descriptions and Specifications
Table 143. Biogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Biogen Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Passive Digital Biomarker Product Picture
Figure 2. Global Passive Digital Biomarker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Physiological Parameters Type Product Picture
Figure 4. Behavioral Activity Type Product Picture
Figure 5. Environmental Factors Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Passive Digital Biomarker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Health Management
Figure 9. Disease Prevention
Figure 10. Clinical Diagnosis
Figure 11. Others
Figure 12. Passive Digital Biomarker Report Years Considered
Figure 13. Global Passive Digital Biomarker Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 15. Global Passive Digital Biomarker Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Passive Digital Biomarker Revenue Market Share by Region (2020-2031)
Figure 17. Global Passive Digital Biomarker Sales (2020-2031) & (K Units)
Figure 18. Global Passive Digital Biomarker Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Passive Digital Biomarker Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Passive Digital Biomarker Sales Volume Market Share in 2024
Figure 21. Global Passive Digital Biomarker Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Physiological Parameters Type Revenue Market Share by Manufacturer in 2024
Figure 24. Behavioral Activity Type Revenue Market Share by Manufacturer in 2024
Figure 25. Environmental Factors Type Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Passive Digital Biomarker Sales Market Share by Type (2020-2031)
Figure 28. Global Passive Digital Biomarker Revenue Market Share by Type (2020-2031)
Figure 29. Global Passive Digital Biomarker Sales Market Share by Application (2020-2031)
Figure 30. Global Passive Digital Biomarker Revenue Market Share by Application (2020-2031)
Figure 31. North America Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 32. North America Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 34. North America Passive Digital Biomarker Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 44. Europe Passive Digital Biomarker Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 49. France Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Passive Digital Biomarker Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 64. India Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Passive Digital Biomarker Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Passive Digital Biomarker Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 85. Passive Digital Biomarker Industry Chain Mapping
Figure 86. Regional Passive Digital Biomarker Manufacturing Base Distribution (%)
Figure 87. Global Passive Digital Biomarker Production Market Share by Region (2020-2031)
Figure 88. Passive Digital Biomarker Production Process
Figure 89. Regional Passive Digital Biomarker Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Table 1. Global Passive Digital Biomarker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Passive Digital Biomarker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Passive Digital Biomarker Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Passive Digital Biomarker Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Passive Digital Biomarker Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Passive Digital Biomarker Sales by Region (2020-2025) & (K Units)
Table 8. Global Passive Digital Biomarker Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Passive Digital Biomarker Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Passive Digital Biomarker Sales Share by Manufacturers (2020-2025)
Table 12. Global Passive Digital Biomarker Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Passive Digital Biomarker Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Passive Digital Biomarker by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Digital Biomarker as of 2024)
Table 16. Global Passive Digital Biomarker Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Passive Digital Biomarker Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Passive Digital Biomarker Manufacturing Base and Headquarters
Table 19. Global Passive Digital Biomarker Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Passive Digital Biomarker Sales by Type (2020-2025) & (K Units)
Table 23. Global Passive Digital Biomarker Sales by Type (2026-2031) & (K Units)
Table 24. Global Passive Digital Biomarker Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Passive Digital Biomarker Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Passive Digital Biomarker ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Passive Digital Biomarker Sales by Application (2020-2025) & (K Units)
Table 29. Global Passive Digital Biomarker Sales by Application (2026-2031) & (K Units)
Table 30. Passive Digital Biomarker High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Passive Digital Biomarker Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Passive Digital Biomarker Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Passive Digital Biomarker ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 37. North America Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 40. Europe Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Passive Digital Biomarker Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Passive Digital Biomarker Growth Accelerators and Market Barriers
Table 45. Southeast Asia Passive Digital Biomarker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Passive Digital Biomarker Investment Opportunities and Key Challenges
Table 47. Central and South America Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Passive Digital Biomarker Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Passive Digital Biomarker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer Passive Digital Biomarker SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. Philips Corporation Information
Table 60. Philips Description and Major Businesses
Table 61. Philips Product Models, Descriptions and Specifications
Table 62. Philips Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Philips Sales Value Proportion by Product in 2024
Table 64. Philips Sales Value Proportion by Application in 2024
Table 65. Philips Sales Value Proportion by Geographic Area in 2024
Table 66. Philips Passive Digital Biomarker SWOT Analysis
Table 67. Philips Recent Developments
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Major Businesses
Table 70. Novartis Product Models, Descriptions and Specifications
Table 71. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novartis Sales Value Proportion by Product in 2024
Table 73. Novartis Sales Value Proportion by Application in 2024
Table 74. Novartis Sales Value Proportion by Geographic Area in 2024
Table 75. Novartis Passive Digital Biomarker SWOT Analysis
Table 76. Novartis Recent Developments
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Major Businesses
Table 79. Johnson & Johnson Product Models, Descriptions and Specifications
Table 80. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 82. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 83. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 84. Johnson & Johnson Passive Digital Biomarker SWOT Analysis
Table 85. Johnson & Johnson Recent Developments
Table 86. GlaxoSmithKline Corporation Information
Table 87. GlaxoSmithKline Description and Major Businesses
Table 88. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 89. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GlaxoSmithKline Sales Value Proportion by Product in 2024
Table 91. GlaxoSmithKline Sales Value Proportion by Application in 2024
Table 92. GlaxoSmithKline Sales Value Proportion by Geographic Area in 2024
Table 93. GlaxoSmithKline Passive Digital Biomarker SWOT Analysis
Table 94. GlaxoSmithKline Recent Developments
Table 95. GE Healthcare Corporation Information
Table 96. GE Healthcare Description and Major Businesses
Table 97. GE Healthcare Product Models, Descriptions and Specifications
Table 98. GE Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. GE Healthcare Recent Developments
Table 100. Asahi Kasei Corporation Information
Table 101. Asahi Kasei Description and Major Businesses
Table 102. Asahi Kasei Product Models, Descriptions and Specifications
Table 103. Asahi Kasei Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Asahi Kasei Recent Developments
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Major Businesses
Table 107. Abbott Laboratories Product Models, Descriptions and Specifications
Table 108. Abbott Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Abbott Laboratories Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Product Models, Descriptions and Specifications
Table 113. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Merck Recent Developments
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Product Models, Descriptions and Specifications
Table 118. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Bayer Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Product Models, Descriptions and Specifications
Table 123. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Sanofi Recent Developments
Table 125. Koneksa Health Corporation Information
Table 126. Koneksa Health Description and Major Businesses
Table 127. Koneksa Health Product Models, Descriptions and Specifications
Table 128. Koneksa Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Koneksa Health Recent Developments
Table 130. Huma Therapeutics Corporation Information
Table 131. Huma Therapeutics Description and Major Businesses
Table 132. Huma Therapeutics Product Models, Descriptions and Specifications
Table 133. Huma Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Huma Therapeutics Recent Developments
Table 135. Roche Corporation Information
Table 136. Roche Description and Major Businesses
Table 137. Roche Product Models, Descriptions and Specifications
Table 138. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Roche Recent Developments
Table 140. Biogen Corporation Information
Table 141. Biogen Description and Major Businesses
Table 142. Biogen Product Models, Descriptions and Specifications
Table 143. Biogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Biogen Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Passive Digital Biomarker Product Picture
Figure 2. Global Passive Digital Biomarker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Physiological Parameters Type Product Picture
Figure 4. Behavioral Activity Type Product Picture
Figure 5. Environmental Factors Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Passive Digital Biomarker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Health Management
Figure 9. Disease Prevention
Figure 10. Clinical Diagnosis
Figure 11. Others
Figure 12. Passive Digital Biomarker Report Years Considered
Figure 13. Global Passive Digital Biomarker Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 15. Global Passive Digital Biomarker Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Passive Digital Biomarker Revenue Market Share by Region (2020-2031)
Figure 17. Global Passive Digital Biomarker Sales (2020-2031) & (K Units)
Figure 18. Global Passive Digital Biomarker Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Passive Digital Biomarker Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Passive Digital Biomarker Sales Volume Market Share in 2024
Figure 21. Global Passive Digital Biomarker Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Physiological Parameters Type Revenue Market Share by Manufacturer in 2024
Figure 24. Behavioral Activity Type Revenue Market Share by Manufacturer in 2024
Figure 25. Environmental Factors Type Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Passive Digital Biomarker Sales Market Share by Type (2020-2031)
Figure 28. Global Passive Digital Biomarker Revenue Market Share by Type (2020-2031)
Figure 29. Global Passive Digital Biomarker Sales Market Share by Application (2020-2031)
Figure 30. Global Passive Digital Biomarker Revenue Market Share by Application (2020-2031)
Figure 31. North America Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 32. North America Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 34. North America Passive Digital Biomarker Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 44. Europe Passive Digital Biomarker Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 49. France Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Passive Digital Biomarker Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 64. India Passive Digital Biomarker Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Passive Digital Biomarker Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Passive Digital Biomarker Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Passive Digital Biomarker Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Passive Digital Biomarker Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Passive Digital Biomarker Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Passive Digital Biomarker Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Passive Digital Biomarker Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Passive Digital Biomarker Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Passive Digital Biomarker Revenue (2020-2025) & (US$ Million)
Figure 85. Passive Digital Biomarker Industry Chain Mapping
Figure 86. Regional Passive Digital Biomarker Manufacturing Base Distribution (%)
Figure 87. Global Passive Digital Biomarker Production Market Share by Region (2020-2031)
Figure 88. Passive Digital Biomarker Production Process
Figure 89. Regional Passive Digital Biomarker Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232